aiqbench analysis

The article focuses on an instance where autonomous AI agents successfully designed a novel drug compound that was subsequently developed by Merck, highlighting a significant breakthrough in generative chemistry and automated research workflows. This development underscores the evolving capability of machine learning systems to perform complex, multi-step tasks traditionally reserved for human scientists, marking a pivotal shift toward fully autonomous discovery pipelines in pharmaceutical R&D.